Comscore Reports Fourth Quarter and Full Year 2024 Results
FY 2024 Financial Highlights
- Revenue for 2024 was
$356.0 million compared to$371.3 million in 2023 - Net loss of
$60.2 million compared to$79.4 million in 2023, resulting primarily from non-cash goodwill impairment charges of$63.0 million and$78.2 million , respectively - Adjusted EBITDA1 of
$42.4 million compared to$44.0 million in 2023 - FX adjusted EBITDA of
$40.9 million compared to$46.9 million in 2023 - Cash, cash equivalents and restricted cash of
$33 .5 million versus$22 .9 million as ofDecember 31, 2023
Q4 2024 Financial Highlights
- Revenue for the fourth quarter was
$94.9 million compared to$95.1 million in Q4 2023 - Net income of
$3 .1 million compared to net loss of$28.4 million in Q4 2023, resulting primarily from a non-cash goodwill impairment charge of$34.1 million in Q4 2023 - Adjusted EBITDA of
$17.2 million compared to$16.4 million in Q4 2023 - FX adjusted EBITDA of
$14.2 million compared to$18.7 million in Q4 2023
2025 Financial Outlook
- Full year revenue expected to be between
$360 million and$370 million - Adjusted EBITDA margin expected to be between 12% and 15% for the year
"We made solid progress in Q4 to establish
Fourth Quarter Summary Results
Revenue in the fourth quarter was
____________________________
1 Adjusted EBITDA, adjusted EBITDA margin and FX Adjusted EBITDA are non-GAAP measures defined in the "Fourth Quarter Summary Results" section and are reconciled to net income (loss) and net income (loss) margin in the addendum of this release. As described in the "2025 Outlook" section, we are unable to provide a reconciliation of adjusted EBITDA or adjusted EBITDA margin on a forward-looking basis because we cannot predict with reasonable certainty our future stock-based compensation expense, fair value adjustments, variable interest expense, litigation and restructuring expense and any unusual items without reasonable effort.
Our core operating expenses, which include cost of revenues, sales and marketing, research and development and general and administrative expenses, were
Net income for the quarter was
Non-GAAP adjusted EBITDA for the quarter was
Full-Year Summary Results
Revenue for 2024 was
Our core operating expenses, which include cost of revenues, sales and marketing, research and development and general and administrative expenses, were
Net loss for the year was
Non-GAAP adjusted EBITDA for the year was
Balance Sheet and Liquidity
As of
On
Prior to entering the new facility, we repaid the outstanding principal balance under our prior credit agreement with
Finally, on
2025 Outlook
Based on current trends and expectations, we believe 2025 revenue will be between
We do not provide GAAP net income (loss) or net income (loss) margin on a forward-looking basis because we are unable to predict with reasonable certainty our future stock-based compensation expense, fair value adjustments, variable interest expense, litigation and restructuring expense and any unusual gains or losses without unreasonable effort. These items are uncertain, depend on various factors, and could be material to results computed in accordance with GAAP. For this reason, we are unable without unreasonable effort to provide a reconciliation of adjusted EBITDA or adjusted EBITDA margin to the most directly comparable GAAP measure, GAAP net income (loss) and net income (loss) margin, on a forward-looking basis.
Conference Call Information for Today, Tuesday,
Management will host a conference call to discuss the results on
About
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal and state securities laws, including, without limitation, our expectations, forecasts, plans and opinions regarding expected revenue and adjusted EBITDA margin for 2025, a return to growth in 2025, revenue drivers, future investments in growth and operational efficiencies, demand for our products, and economic and industry trends. These statements involve risks and uncertainties that could cause actual events to differ materially from expectations, including, but not limited to, changes in our business and customer, partner and vendor relationships; external market conditions and competition; continued changes or declines in ad spending or other macroeconomic factors; evolving privacy and regulatory standards; product adoption rates; and our ability to achieve our expected strategic, financial and operational plans. For additional discussion of risk factors, please refer to our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and other filings that we make from time to time with the
Investors are cautioned not to place undue reliance on our forward-looking statements, which speak only as of the date such statements are made. We do not intend or undertake, and expressly disclaim, any duty or obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after the date of this press release, or to reflect the occurrence of unanticipated events.
Use of Non-GAAP Financial Measures
To provide investors with additional information regarding our financial results, we are disclosing in this press release adjusted EBITDA, adjusted EBITDA margin and FX adjusted EBITDA, which are non-GAAP financial measures used by our management to understand and evaluate our core operating performance and trends. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results, as they permit our investors to view our core business performance using the same metrics that management uses to evaluate our performance. Nevertheless, our use of these non-GAAP financial measures has limitations as an analytical tool, and investors should not consider these measures in isolation or as a substitute for analysis of our results as reported under GAAP. Instead, you should consider these measures alongside GAAP-based financial performance measures, net income (loss), net income (loss) margin, various cash flow metrics, and our other GAAP financial results. Set forth below are reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures, net income (loss) and net income (loss) margin. These reconciliations should be carefully evaluated.
Media
Marie Scoutas
press@comscore.com
Investors
212-203-2129
jtinker@comscore.com
CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data) |
|||||||
| As of |
|||||||
| 2024 | 2023 | ||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 29,937 | $ | 22,750 | |||
| Restricted cash | 3,531 | 186 | |||||
| Accounts receivable, net of allowances of |
64,266 | 63,826 | |||||
| Prepaid expenses and other current assets | 10,323 | 11,228 | |||||
| Total current assets | 108,057 | 97,990 | |||||
| Property and equipment, net | 47,116 | 41,574 | |||||
| Operating right-of-use assets | 13,173 | 18,628 | |||||
| Deferred tax assets | 2,624 | 2,588 | |||||
| Intangible assets, net | 5,058 | 8,115 | |||||
| 246,010 | 310,360 | ||||||
| Other non-current assets | 8,209 | 12,040 | |||||
| Total assets | $ | 430,247 | $ | 491,295 | |||
| Liabilities, Convertible Redeemable Preferred Stock and Stockholders' Equity (Deficit) | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 16,471 | $ | 30,551 | |||
| Accrued expenses | 35,013 | 34,422 | |||||
| Contract liabilities | 45,464 | 48,912 | |||||
| Revolving line of credit | — | 16,000 | |||||
| Accrued dividends | 8,962 | 24,132 | |||||
| Customer advances | 9,566 | 11,076 | |||||
| Current operating lease liabilities | 8,598 | 7,982 | |||||
| Other current liabilities | 7,230 | 9,486 | |||||
| Total current liabilities | 131,304 | 182,561 | |||||
| Secured term loan | 40,718 | — | |||||
| Non-current operating lease liabilities | 14,805 | 23,003 | |||||
| Non-current portion of accrued data costs | 33,551 | 32,833 | |||||
| Deferred tax liabilities | 891 | 1,321 | |||||
| Other non-current liabilities | 9,771 | 7,589 | |||||
| Total liabilities | 231,040 | 247,307 | |||||
| Commitments and contingencies | |||||||
| Convertible redeemable preferred stock, |
207,470 | 187,885 | |||||
| Stockholders' equity (deficit): | |||||||
| Preferred stock, |
— | — | |||||
| Common stock, |
5 | 5 | |||||
| Additional paid-in capital | 1,714,052 | 1,696,612 | |||||
| Accumulated other comprehensive loss | (18,068 | ) | (14,110 | ) | |||
| Accumulated deficit | (1,474,268 | ) | (1,396,420 | ) | |||
| (229,984 | ) | (229,984 | ) | ||||
| Total stockholders' equity (deficit) | (8,263 | ) | 56,103 | ||||
| Total liabilities, convertible redeemable preferred stock and stockholders' equity (deficit) | $ | 430,247 | $ | 491,295 | |||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands, except share and per share data) |
|||||||||||
| Years Ended |
|||||||||||
| 2024 | 2023 | 2022 | |||||||||
| Revenues | $ | 356,047 | $ | 371,343 | $ | 376,423 | |||||
| Cost of revenues (1) (2) | 208,708 | 205,580 | 205,294 | ||||||||
| Selling and marketing (1) (2) | 57,622 | 63,322 | 68,453 | ||||||||
| Research and development (1) (2) | 33,066 | 33,701 | 36,987 | ||||||||
| General and administrative (1) (2) | 47,679 | 51,192 | 61,200 | ||||||||
| Amortization of intangible assets | 3,057 | 5,213 | 27,096 | ||||||||
| Impairment of goodwill | 63,000 | 78,200 | 46,300 | ||||||||
| Impairment of right-of-use and long-lived assets | 1,397 | 1,502 | 156 | ||||||||
| Restructuring | 1,027 | 6,234 | 5,810 | ||||||||
| Total expenses from operations | 415,556 | 444,944 | 451,296 | ||||||||
| Loss from operations | (59,509 | ) | (73,601 | ) | (74,873 | ) | |||||
| Interest expense, net | (1,883 | ) | (1,445 | ) | (915 | ) | |||||
| Other income, net | 651 | 42 | 9,785 | ||||||||
| Gain (loss) from foreign currency transactions | 1,417 | (2,824 | ) | 1,166 | |||||||
| Loss before income taxes | (59,324 | ) | (77,828 | ) | (64,837 | ) | |||||
| Income tax provision | (924 | ) | (1,533 | ) | (1,724 | ) | |||||
| Net loss | $ | (60,248 | ) | $ | (79,361 | ) | $ | (66,561 | ) | ||
| Net loss available to common stockholders | |||||||||||
| Net loss | (60,248 | ) | (79,361 | ) | (66,561 | ) | |||||
| Convertible redeemable preferred stock dividends | (17,600 | ) | (16,270 | ) | (15,513 | ) | |||||
| Total net loss available to common stockholders | $ | (77,848 | ) | $ | (95,631 | ) | $ | (82,074 | ) | ||
| Net loss per common share (3): | |||||||||||
| Basic and diluted | $ | (15.53 | ) | $ | (19.88 | ) | $ | (17.71 | ) | ||
| Weighted-average number of shares used in per share calculation - Common Stock (3): | |||||||||||
| Basic and diluted | 5,014,049 | 4,811,233 | 4,634,178 | ||||||||
| Comprehensive loss: | |||||||||||
| Net loss | $ | (60,248 | ) | $ | (79,361 | ) | $ | (66,561 | ) | ||
| Other comprehensive loss: | |||||||||||
| Foreign currency cumulative translation adjustment | (3,958 | ) | 1,830 | (3,842 | ) | ||||||
| Total comprehensive loss | $ | (64,206 | ) | $ | (77,531 | ) | $ | (70,403 | ) | ||
| (1) Excludes amortization of intangible assets, which is presented separately in the Consolidated Statements of Operations and Comprehensive Loss. | |||||||||||
| (2) Stock-based compensation expense is included in the line items above as follows: | |||||||||||
| Years Ended |
|||||||||||
| 2024 | 2023 | 2022 | |||||||||
| Cost of revenues | $ | 221 | $ | 533 | $ | 1,144 | |||||
| Selling and marketing | 126 | 380 | 1,021 | ||||||||
| Research and development | 161 | 411 | 827 | ||||||||
| General and administrative | 2,683 | 3,211 | 5,186 | ||||||||
| Total stock-based compensation expense | $ | 3,191 | $ | 4,535 | $ | 8,178 | |||||
| (3) Adjusted retroactively for a 1-for-20 reverse split of our common stock effected on |
|||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) |
|||||||||||
| Years Ended |
|||||||||||
| 2024 | 2023 | 2022 | |||||||||
| Operating activities: | |||||||||||
| Net loss | $ | (60,248 | ) | $ | (79,361 | ) | $ | (66,561 | ) | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||
| Impairment of goodwill | 63,000 | 78,200 | 46,300 | ||||||||
| Depreciation | 22,087 | 19,778 | 16,828 | ||||||||
| Non-cash operating lease expense | 5,240 | 5,456 | 6,060 | ||||||||
| Amortization expense of finance leases | 3,651 | 1,929 | 2,364 | ||||||||
| Stock-based compensation expense | 3,191 | 4,535 | 8,178 | ||||||||
| Amortization of intangible assets | 3,057 | 5,213 | 27,096 | ||||||||
| Impairment of right-of-use and long-lived assets | 1,397 | 1,502 | 156 | ||||||||
| Change in fair value of warrant liability | (669 | ) | (49 | ) | (9,802 | ) | |||||
| Deferred tax provision | (841 | ) | (35 | ) | (475 | ) | |||||
| Other | 2,008 | 2,297 | 4,468 | ||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | (1,649 | ) | 4,781 | 2,596 | |||||||
| Prepaid expenses and other assets | 1,987 | 2,185 | (805 | ) | |||||||
| Accounts payable, accrued expenses, and other liabilities | (10,570 | ) | (4,121 | ) | 7,396 | ||||||
| Contract liability and customer advances | (4,739 | ) | (5,517 | ) | (1,587 | ) | |||||
| Operating lease liabilities | (8,798 | ) | (7,867 | ) | (7,275 | ) | |||||
| Net cash provided by operating activities | 18,104 | 28,926 | 34,937 | ||||||||
| Investing activities: | |||||||||||
| Capitalized internal-use software costs | (23,249 | ) | (22,206 | ) | (16,685 | ) | |||||
| Purchases of property and equipment | (813 | ) | (1,580 | ) | (1,137 | ) | |||||
| Net cash used in investing activities | (24,062 | ) | (23,786 | ) | (17,822 | ) | |||||
| Financing activities: | |||||||||||
| Proceeds from secured term loan | 45,000 | — | — | ||||||||
| Proceeds from insurance financing | 2,118 | — | — | ||||||||
| Payments for dividends on convertible redeemable preferred stock | — | — | (15,512 | ) | |||||||
| Principal payments on insurance financing | (2,122 | ) | — | — | |||||||
| Principal payments on finance leases | (2,852 | ) | (2,066 | ) | (2,519 | ) | |||||
| Contingent consideration payment at initial value | (3,704 | ) | (1,037 | ) | — | ||||||
| Payments of debt issuance costs | (4,551 | ) | — | — | |||||||
| Payments of line of credit | (16,000 | ) | — | — | |||||||
| Other | (266 | ) | (291 | ) | (101 | ) | |||||
| Net cash provided by (used in) financing activities | 17,623 | (3,394 | ) | (18,132 | ) | ||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (1,133 | ) | 748 | (820 | ) | ||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 10,532 | 2,494 | (1,837 | ) | |||||||
| Cash, cash equivalents and restricted cash at beginning of period | 22,936 | 20,442 | 22,279 | ||||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 33,468 | $ | 22,936 | $ | 20,442 | |||||
| As of |
|||||||||||
| 2024 | 2023 | 2022 | |||||||||
| Cash and cash equivalents | $ | 29,937 | $ | 22,750 | $ | 20,044 | |||||
| Restricted cash | 3,531 | 186 | 398 | ||||||||
| Total cash, cash equivalents and restricted cash | $ | 33,468 | $ | 22,936 | $ | 20,442 | |||||
Reconciliation of Non-GAAP Financial Measures
The following table presents a reconciliation of GAAP net loss and net loss margin to non-GAAP adjusted EBITDA, adjusted EBITDA margin and non-GAAP FX adjusted EBITDA for each of the periods identified:
| Years Ended |
||||||||||||||
| 2024 | 2023 | 2022 | ||||||||||||
| (In thousands) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||
| GAAP net loss | $ | (60,248 | ) | $ | (79,361 | ) | $ | (66,561 | ) | |||||
| Depreciation | 22,087 | 19,778 | 16,828 | |||||||||||
| Amortization expense of finance leases | 3,651 | 1,929 | 2,364 | |||||||||||
| Amortization of intangible assets | 3,057 | 5,213 | 27,096 | |||||||||||
| Interest expense, net | 1,883 | 1,445 | 915 | |||||||||||
| Income tax provision | 924 | 1,533 | 1,724 | |||||||||||
| EBITDA | (28,646 | ) | (49,463 | ) | (17,634 | ) | ||||||||
| Adjustments: | ||||||||||||||
| Impairment of goodwill | 63,000 | 78,200 | 46,300 | |||||||||||
| Stock-based compensation expense | 3,191 | 4,535 | 8,178 | |||||||||||
| Transformation costs (1) | 1,547 | 1,283 | 460 | |||||||||||
| Amortization of cloud-computing implementation costs | 1,420 | 1,439 | 1,435 | |||||||||||
| Impairment of right-of-use and long-lived assets | 1,397 | 1,502 | 156 | |||||||||||
| Restructuring | 1,027 | 6,234 | 5,810 | |||||||||||
| Change in fair value of contingent consideration liability | 89 | 350 | 2,558 | |||||||||||
| Loss on asset disposition | 6 | — | 7 | |||||||||||
| Other income, net (2) | (669 | ) | (49 | ) | (9,802 | ) | ||||||||
| Non-GAAP adjusted EBITDA | $ | 42,362 | $ | 44,031 | $ | 37,468 | ||||||||
| Net loss margin (3) | (16.9 | ) | % | (21.4 | ) | % | (17.7 | ) | % | |||||
| Non-GAAP adjusted EBITDA margin (4) | 11.9 | % | 11.9 | % | 10.0 | % | ||||||||
| Adjustments: | ||||||||||||||
| (Gain) Loss from foreign currency transactions | (1,417 | ) | 2,824 | (1,166 | ) | |||||||||
| Non-GAAP FX adjusted EBITDA | $ | 40,945 | $ | 46,855 | $ | 36,302 | ||||||||
| (1) Transformation costs represent: (1) expenses incurred prior to formal launch of identified strategic projects with anticipated long-term benefits to the company, generally relating to third-party professional fees and non-capitalizable technology costs tied directly to the identified projects and (2) severance costs associated with the reorganization of our teams in connection with the identified projects. We added transformation costs as an adjustment in 2023 for greater transparency around these costs and have applied the adjustment to prior periods for comparison. | ||||||||||||||
| (2) Adjustments to other income, net reflect non-cash changes in the fair value of warrants liability included in other income, net on our Consolidated Statements of Operations and Comprehensive Loss. | ||||||||||||||
| (3) Net loss margin is calculated by dividing net loss by revenues reported on our Consolidated Statements of Operations and Comprehensive Loss for the applicable period. | ||||||||||||||
| (4) Non-GAAP Adjusted EBITDA margin is calculated by dividing adjusted EBITDA by revenues reported on our Consolidated Statements of Operations and Comprehensive Loss for the applicable period. | ||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) (In thousands, except share and per share data) |
|||||||
| Three Months Ended |
|||||||
| 2024 | 2023 | ||||||
| Revenues | $ | 94,936 | $ | 95,101 | |||
| Cost of revenues (1) (2) | 54,683 | 50,220 | |||||
| Selling and marketing (1) (2) | 14,931 | 14,338 | |||||
| Research and development (1) (2) | 8,654 | 7,909 | |||||
| General and administrative (1) (2) | 12,016 | 11,416 | |||||
| Amortization of intangible assets | 692 | 801 | |||||
| Restructuring | 59 | 779 | |||||
| Impairment of goodwill | — | 34,100 | |||||
| Total expenses from operations | 91,035 | 119,563 | |||||
| Income (loss) from operations | 3,901 | (24,462 | ) | ||||
| Interest expense, net | (443 | ) | (304 | ) | |||
| Other expense, net | — | (383 | ) | ||||
| Gain (loss) from foreign currency transactions | 2,925 | (2,280 | ) | ||||
| Income (loss) before income taxes | 6,383 | (27,429 | ) | ||||
| Income tax provision | (3,239 | ) | (970 | ) | |||
| Net income (loss) | $ | 3,144 | $ | (28,399 | ) | ||
| Net loss available to common stockholders: | |||||||
| Net income (loss) | 3,144 | (28,399 | ) | ||||
| Convertible redeemable preferred stock dividends | (4,538 | ) | (4,287 | ) | |||
| Total net loss available to common stockholders | $ | (1,394 | ) | $ | (32,686 | ) | |
| Net loss per common share: | |||||||
| Basic and diluted | $ | (0.27 | ) | $ | (6.69 | ) | |
| Weighted-average number of shares used in per share calculation - Common Stock: | |||||||
| Basic and diluted | 5,096,459 | 4,888,089 | |||||
| Comprehensive loss: | |||||||
| Net income (loss) | $ | 3,144 | $ | (28,399 | ) | ||
| Other comprehensive loss: | |||||||
| Foreign currency cumulative translation adjustment | (4,786 | ) | 2,699 | ||||
| Total comprehensive loss | $ | (1,642 | ) | $ | (25,700 | ) | |
| (1) Excludes amortization of intangible assets, which is presented separately in the Consolidated Statements of Operations and Comprehensive Loss. | |||||||
| (2) Stock-based compensation expense is included in the line items above as follows: | |||||||
| Three Months Ended |
|||||||
| 2024 | 2023 | ||||||
| Cost of revenues | $ | 103 | $ | 98 | |||
| Selling and marketing | 55 | (31 | ) | ||||
| Research and development | 69 | 78 | |||||
| General and administrative | 697 | 571 | |||||
| Total stock-based compensation expense | $ | 924 | $ | 716 | |||
Reconciliation of Non-GAAP Financial Measures
The following table presents a reconciliation of GAAP net income (loss) and net income (loss) margin to non-GAAP adjusted EBITDA, adjusted EBITDA margin and non-GAAP FX adjusted EBITDA for each of the periods identified:
| Three Months Ended |
|||||||||
| 2024 | 2023 | ||||||||
| (In thousands) | (Unaudited) | (Unaudited) | |||||||
| GAAP net income (loss) | $ | 3,144 | $ | (28,399 | ) | ||||
| Depreciation | 5,893 | 5,165 | |||||||
| Income tax provision | 3,239 | 970 | |||||||
| Amortization expense of finance leases | 960 | 661 | |||||||
| Amortization of intangible assets | 692 | 801 | |||||||
| Interest expense, net | 443 | 304 | |||||||
| EBITDA | 14,371 | (20,498 | ) | ||||||
| Adjustments: | |||||||||
| Transformation costs (1) | 1,472 | 530 | |||||||
| Stock-based compensation expense | 924 | 716 | |||||||
| Amortization of cloud-computing implementation costs | 345 | 361 | |||||||
| Restructuring | 59 | 779 | |||||||
| Impairment of goodwill | — | 34,100 | |||||||
| Change in fair value of contingent consideration liability | — | 98 | |||||||
| Other expense, net (2) | — | 358 | |||||||
| Non-GAAP adjusted EBITDA | $ | 17,171 | $ | 16,444 | |||||
| Net income (loss) margin (3) | 3.3 | % | (29.9 | ) | % | ||||
| Non-GAAP adjusted EBITDA margin (4) | 18.1 | % | 17.3 | % | |||||
| Adjustments: | |||||||||
| (Gain) Loss from foreign currency transactions | (2,925 | ) | 2,280 | ||||||
| Non-GAAP FX adjusted EBITDA | $ | 14,246 | $ | 18,724 | |||||
| (1) Transformation costs represent: (1) expenses incurred prior to formal launch of identified strategic projects with anticipated long-term benefits to the company, generally relating to third-party professional fees and non-capitalizable technology costs tied directly to the identified projects and (2) severance costs associated with the reorganization of our teams in connection with the identified projects. | |||||||||
| (2) Adjustments to other expense, net reflect non-cash changes in the fair value of warrants liability included in other expense, net on our Consolidated Statements of Operations and Comprehensive Loss. | |||||||||
| (3) Net income (loss) margin is calculated by dividing net income (loss) by revenues reported on our Consolidated Statements of Operations and Comprehensive Loss for the applicable period. | |||||||||
| (4) Non-GAAP Adjusted EBITDA margin is calculated by dividing adjusted EBITDA by revenues reported on our Consolidated Statements of Operations and Comprehensive Loss for the applicable period. | |||||||||
Revenues
Revenues from our offerings of products and services are as follows:
| Years Ended |
|||||||||||||||||||||||
| (In thousands) | 2024 | % of Revenue | 2023 | % of Revenue | $ Variance | % Variance | |||||||||||||||||
| Content & Ad Measurement | |||||||||||||||||||||||
| Syndicated Audience (1) | $ | 260,654 | 73.2 | % | $ | 276,101 | 74.4 | % | $ | (15,447 | ) | (5.6 | ) | % | |||||||||
| Cross-Platform | 40,470 | 11.4 | % | 33,803 | 9.1 | % | 6,667 | 19.7 | % | ||||||||||||||
| Total Content & Ad Measurement | 301,124 | 84.6 | % | 309,904 | 83.5 | % | (8,780 | ) | (2.8 | ) | % | ||||||||||||
| Research & Insight Solutions | 54,923 | 15.4 | % | 61,439 | 16.5 | % | (6,516 | ) | (10.6 | ) | % | ||||||||||||
| Total revenues | $ | 356,047 | 100.0 | % | $ | 371,343 | 100.0 | % | $ | (15,296 | ) | (4.1 | ) | % | |||||||||
| (1) Syndicated Audience revenue includes revenue from our movies business, which grew from |
|||||||||||||||||||||||
| Three Months Ended |
|||||||||||||||||||||||
| (In thousands) | 2024 (Unaudited) |
% of Revenue | 2023 (Unaudited) |
% of Revenue | $ Variance | % Variance |
|||||||||||||||||
| Content & Ad Measurement | |||||||||||||||||||||||
| Syndicated Audience (1) | $ | 66,823 | 70.4 | % | $ | 68,550 | 72.1 | % | $ | (1,727 | ) | (2.5 | ) | % | |||||||||
| Cross-Platform | 14,218 | 15.0 | % | 11,686 | 12.3 | % | 2,532 | 21.7 | % | ||||||||||||||
| Total Content & Ad Measurement | 81,041 | 85.4 | % | 80,236 | 84.4 | % | 805 | 1.0 | % | ||||||||||||||
| Research & Insight Solutions | 13,895 | 14.6 | % | 14,865 | 15.6 | % | (970 | ) | (6.5 | ) | % | ||||||||||||
| Total revenues | $ | 94,936 | 100.0 | % | $ | 95,101 | 100.0 | % | $ | (165 | ) | (0.2 | ) | % | |||||||||
| (1) Syndicated Audience revenue includes revenue from our movies business, which grew from |
|||||||||||||||||||||||
| Three Months Ended (Unaudited) | Year Ended | ||||||||||||||||||||||
| (In thousands) | % of Total 2024 Revenue | ||||||||||||||||||||||
| Content & Ad Measurement | |||||||||||||||||||||||
| Syndicated Audience | $ | 64,600 | $ | 64,189 | $ | 65,042 | $ | 66,823 | $ | 260,654 | 73.2 | % | |||||||||||
| Cross-Platform | 8,020 | 8,000 | 10,232 | 14,218 | 40,470 | 11.4 | % | ||||||||||||||||
| Total Content & Ad Measurement | 72,620 | 72,189 | 75,274 | 81,041 | 301,124 | 84.6 | % | ||||||||||||||||
| Research & Insight Solutions | 14,175 | 13,648 | 13,205 | 13,895 | 54,923 | 15.4 | % | ||||||||||||||||
| Total revenues | $ | 86,795 | $ | 85,837 | $ | 88,479 | $ | 94,936 | $ | 356,047 | 100.0 | % | |||||||||||
Source: Comscore, Inc.